Search results
Results from the WOW.Com Content Network
On Ginkgo's (DNA) third-quarter earnings call, investor focus is likely to be on the company's progress with its collaboration deals and the performance of its business units.
Meanwhile, companies reporting disappointing earnings are getting punished, falling 5.6% during the same window. This is much worse than the five-year average loss of 2.2%.
Applied DNA Sciences (APDN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TMO earnings call for the period ending December 31, 2024. ... if you invested $1,000 at the time of our recommendation, ... we launched the Applied Biosystems MagMAX Sequential DNA/RNA kit, which ...
The Greatest of All Time ₹440–456 crore Tamil 2024 [n] 13 Vikram ₹424–500 crore Tamil 2022 [o] 14 Saaho [p] ₹419–434 crore Telugu 2019 [q] 15 Devara: Part 1 ₹403.80–521 crore: Telugu 2024 [r] 16 Kantara ₹400–450 crore Kannada 2022 [s] 17 Pushpa: The Rise ₹360–373 crore Telugu 2021 [t] 18 Ponniyin Selvan: II ₹345 crore ...
U.S. stocks closed higher as investors digested a slew of corporate earnings reports, including some from the so-called Magnificent 7. The broad S&P 500 index closed up 0.51%, or 31.86 points, to ...
OGI earnings call for the period ending December 31, 2024. ... At this time, I would like to welcome everyone to the Organigram Holdings first-quarter fiscal 2025 earnings conference call ...
The Greatest of All Time ₹440–456 crore Tamil 2024 [ac] 31 Vikram ₹424–500 crore Tamil 2022 [ad] 32 Saaho ₹419–439 crore Telugu Hindi 2019 [ae] 33 Brahmāstra: Part One – Shiva ₹418.80–430.77 crore Hindi 2022 [af] 34 Chhaava † ₹409.97 crore: Hindi 2025 [95] 35 Devara: Part 1 ₹403.80–521 crore: Telugu 2024 [ag] 36 ...